Submissions for variant NM_000144.5(FXN):c.11_12del (p.Leu4fs)

dbSNP: rs143232208

Total submissions: 2

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
Ambry Genetics	RCV002310848	SCV000318626	likely pathogenic	Inborn genetic diseases	2015-12-24	criteria provided, single submitter	clinical testing	The c.11_12delTC variant, located in coding exon 1 of the FXN gene, results from a deletion of two nucleotides between nucleotide positions 11 and 12, causing a translational frameshift with a predicted alternate stop codon (p.L4Rfs*88). This variant was observed in two Malaysian siblings, both exhibiting features of Friedreich ataxia including nonobstructive hypertrophic cardiomyopathy. These siblings were compound heterozygotes, carrying this alteration and a repeat expansion mutation on the opposite allele. This variant was inherited from their mother, and both parents were clinically unaffected (Spacey SD, Can J Neurol Sci 2004 Aug; 31(3):383-6). This variant was also reported in another cohort of patients with Friedreich ataxia (Lazaropoulos M. Ann Clin Transl Neurol. 2015 Aug;2(8):831-42). This variant was previously reported in the SNPDatabase as rs143232208. This variant was not reported in population-based cohorts in the following databases: NHLBI Exome Sequencing Project (ESP) and 1000 Genomes Project. While truncating alterations in FXN are not a common cause of Friedreich ataxia and their functional consequences have not been well described, frameshifts are typically deleterious in nature (ACMG Standards and guidelines for the interpretation of sequence variants. Genet Med. 2015;17(5):405-24). Based on the majority of available evidence to date, this variant is likely to be pathogenic when in trans with another FXN mutation; however, expression and severity cannot be predicted.
GeneDx	RCV003324738	SCV004030732	pathogenic	not provided	2023-08-23	criteria provided, single submitter	clinical testing	Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26339677, 28789479, 15376485)